longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

PRME

PRME
3.4702.53%( -0.090 )

LongbridgeAI

This Caseys Analyst Turns Bullish; Here Are Top 3 Upgrades For Monday

benzinga_article
Jun 29, 2026 at 12:42 PM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

Wall Street analysts upgraded three stocks: HC Wainwright upgraded Prime Medicine to Buy with an $8 target; BMO Capital upgraded Casey's General Stores to Outperform, maintaining a $950 target; and Seaport Global upgraded Warner Bros Discovery to Buy with a $31 target.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • HC Wainwright & Co. analyst Arthur He upgraded Prime Medicine, Inc (NASDAQ:PRME) from Neutral to Buy and announced a price target of $8. Prime Medicine shares closed at $3.43 on Friday. See how other analysts view this stock.
  • BMO Capital analyst Kelly Bania upgraded Caseys General Stores Inc (NASDAQ:CASY) from Market Perform to Outperform and maintained the price target of $950. Casey’s shares closed at $778.63 on Friday. See how other analysts view this stock.
  • Seaport Global analyst David Joyce upgraded Warner Bros Discovery Inc (NASDAQ:WBD) from Neutral to Buy and announced a $31 price target. Warner Bros. Discovery shares closed at $26.74 on Friday. See how other analysts view this stock.

Considering buying CASY stock? Here’s what analysts think:

Photo via Shutterstock

Login to unlock510characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Related Stocks

Casey General Stores

Casey General Stores

USCASY

-14.24%

Prime Medicine

Prime Medicine

USPRME

-2.53%

Warner Bros. Discovery

Warner Bros. Discovery

USWBD

-0.75%